A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas - Archive ouverte HAL Access content directly
Journal Articles Journal of Neuro-Oncology Year : 2017

A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas

(1) , (2) , (3)
1
2
3
Not file

Dates and versions

hal-03905482 , version 1 (18-12-2022)

Identifiers

Cite

Stéphane Goutagny, Marco Giovannini, Michel Kalamarides. A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas. Journal of Neuro-Oncology, 2017, 133 (2), pp.443-445. ⟨10.1007/s11060-017-2447-3⟩. ⟨hal-03905482⟩
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More